Determinants of Hepatitis C Virus Treatment Completion and Efficacy in Drug Users Assessed by Meta-analysis

Hepatitis C virus infection in USA: an estimate of true prevalence

(2011) Eric Chak et al.   LIVER INTERNATIONAL

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

(2011) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

(2011) Ira M. Jacobson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical experience with the treatment of hepatitis C infection in patients on opioid pharmacotherapy

(2010) Joseph John Sasadeusz et al.   ADDICTION

Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States☆☆☆

(2010) David B. Rein et al.   DIGESTIVE AND LIVER DISEASE

Successful treatment of chronic hepatitis C virus infection in severely opioid-dependent patients under heroin maintenance

(2010) Bernd Schulte et al.   DRUG AND ALCOHOL DEPENDENCE

Treatment for hepatitis C virus genotype 1 infection in HIV-infected individuals on methadone maintenance therapy

(2010) Lynn E. Taylor et al.   DRUG AND ALCOHOL DEPENDENCE

Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study

(2010) Pascal Melin et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Hepatitis C testing and treatment among active drug users in Amsterdam

(2010) Catharina E.A. Lindenburg et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Successful Integration of Hepatitis C Evaluation and Treatment Services With Methadone Maintenance

(2010) Kenneth A. Harris et al.   Journal of Addiction Medicine

Together … to Take Care: Multidisciplinary Management of Hepatitis C Virus Treatment in Randomly Selected Drug Users With Chronic Hepatitis

(2010) Fabio Curcio et al.   Journal of Addiction Medicine

The natural history of hepatitis C infection acquired through injection drug use: Meta-analysis and meta-regression

(2010) Ava John-Baptiste et al.   JOURNAL OF HEPATOLOGY

Estimating the likelihood of sustained virological response in chronic hepatitis C therapy

(2010) S. Mauss et al.   JOURNAL OF VIRAL HEPATITIS

Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance

(2010) A. D. Martinez et al.   JOURNAL OF VIRAL HEPATITIS

Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C

(2010) Spilios Manolakopoulos et al.   LIVER INTERNATIONAL

Efficiency of a combined peginterferon alpha-2a and ribavarin therapy in intravenous opiate substances abusers with chronic hepatitis C

(2010) Maja Jovanovic et al.   Vojnosanitetski Pregled

Determinants of successful chronic hepatitis C case finding among patients receiving opioid maintenance treatment in a primary care setting

(2009) Oliver Senn et al.   ADDICTION

Retention rate and side effects in a prospective trial on hepatitis C treatment with pegylated interferon alpha-2a and ribavirin in opioid-dependent patients

(2009) Nina Ebner et al.   ADDICTION BIOLOGY

Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study

(2009) J. Grebely et al.   DRUG AND ALCOHOL DEPENDENCE

Peginterferon/ribavirin treatment achieves a higher compliance rate than interferon/ribavirin combination in patients chronically infected with HCV on methadone maintenance

(2009) Dimitrios Dimitroulopoulos et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression

(2009) Gary L. Davis et al.   GASTROENTEROLOGY

The impact of a managed care network on attendance, follow-up and treatment at a hepatitis C specialist centre

(2009) J. M. Tait et al.   JOURNAL OF VIRAL HEPATITIS

Factors associated with treatment failure of patients with psychiatric diseases and injecting drug users in the treatment of genotype 2 or 3 hepatitis C chronic infection

(2009) Gerardo Alvarez-Uria et al.   LIVER INTERNATIONAL

Clinical trial: a primary-care-based model for the delivery of anti-viral treatment to injecting drug users infected with hepatitis C

(2008) K. JACK et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Community-based treatment for chronic hepatitis C in drug users: high rates of compliance with therapy despite ongoing drug use

(2008) M. WILKINSON et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Efficacy and Safety of Peginterferon Alfa-2a/Ribavirin in Methadone Maintenance Patients: Randomized Comparison of Direct Observed Therapy and Self-Administration

(2008) Herbert L. Bonkovsky et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Swiss Multicenter Study Evaluating the Efficacy, Feasibility and Safety of Peginterferon-Alfa-2a and Ribavirin in Patients with Chronic Hepatitis C in Official Opiate Substitution Programs

(2008) Ronald Fried et al.   DIGESTION

Peginterferon plus Ribavirin for chronic hepatitis C in opiate addicts on methadone/buprenorphine maintenance therapy

(2008) B. Belfiori et al.   DIGESTIVE AND LIVER DISEASE

Diagnosis, management, and treatment of hepatitis C: An update

(2008) Marc G. Ghany et al.   HEPATOLOGY

Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patients

(2008) P. Bruggmann et al.   JOURNAL OF VIRAL HEPATITIS

Barriers associated with the treatment of hepatitis C virus infection among illicit drug users

(2007) Jason Grebely et al.   DRUG AND ALCOHOL DEPENDENCE